Morgan Stanley Valuation
Is MS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MS (CHF42.2) is trading below our estimate of fair value (CHF57.78)
Significantly Below Fair Value: MS is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MS?
Other financial metrics that can be useful for relative valuation.
| What is MS's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$164.84b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 2x |
Price to Earnings Ratio vs Peers
How does MS's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 26x | ||
SQN Swissquote Group Holding | 17.8x | 13.1% | CHF 4.6b |
UBSG UBS Group | 42x | 33.3% | CHF 84.6b |
CFT Compagnie Financière Tradition | 12.4x | n/a | CHF 1.2b |
PGHN Partners Group Holding | 31.8x | 13.5% | CHF 31.9b |
MS Morgan Stanley | 16.7x | 8.3% | CHF 164.8b |
Price-To-Earnings vs Peers: MS is good value based on its Price-To-Earnings Ratio (16.7x) compared to the peer average (26x).
Price to Earnings Ratio vs Industry
How does MS's PE Ratio compare vs other companies in the European Capital Markets Industry?
Price-To-Earnings vs Industry: MS is expensive based on its Price-To-Earnings Ratio (16.7x) compared to the European Capital Markets industry average (14.9x).
Price to Earnings Ratio vs Fair Ratio
What is MS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 16.7x |
| Fair PE Ratio | 19.8x |
Price-To-Earnings vs Fair Ratio: MS is good value based on its Price-To-Earnings Ratio (16.7x) compared to the estimated Fair Price-To-Earnings Ratio (19.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 42.20 | CHF 90.54 +114.6% | 9.2% | CHF 104.30 | CHF 77.80 | n/a | 18 |
| Aug ’25 | CHF 42.20 | CHF 92.52 +119.2% | 9.2% | CHF 106.58 | CHF 79.50 | n/a | 18 |
| Jul ’25 | CHF 42.20 | CHF 89.85 +112.9% | 8.4% | CHF 106.56 | CHF 80.37 | n/a | 21 |
| Jun ’25 | CHF 42.20 | CHF 90.63 +114.8% | 8.3% | CHF 107.44 | CHF 81.04 | n/a | 21 |
| May ’25 | CHF 42.20 | CHF 90.97 +115.6% | 8.8% | CHF 108.46 | CHF 80.88 | n/a | 21 |
| Apr ’25 | CHF 42.20 | CHF 86.07 +104.0% | 8.7% | CHF 104.92 | CHF 75.08 | n/a | 21 |
| Mar ’25 | CHF 42.20 | CHF 83.12 +97.0% | 9.3% | CHF 101.45 | CHF 73.38 | n/a | 21 |
| Feb ’25 | CHF 42.20 | CHF 81.69 +93.6% | 9.6% | CHF 99.95 | CHF 68.93 | n/a | 21 |
| Jan ’25 | CHF 42.20 | CHF 78.33 +85.6% | 8.9% | CHF 91.54 | CHF 68.44 | n/a | 22 |
| Dec ’24 | CHF 42.20 | CHF 78.07 +85.0% | 9.6% | CHF 91.94 | CHF 64.44 | n/a | 22 |
| Nov ’24 | CHF 42.20 | CHF 82.12 +94.6% | 9.6% | CHF 98.94 | CHF 66.20 | n/a | 22 |
| Oct ’24 | CHF 42.20 | CHF 89.53 +112.2% | 8.8% | CHF 102.50 | CHF 73.22 | n/a | 23 |
| Sep ’24 | CHF 42.20 | CHF 86.93 +106.0% | 9.0% | CHF 99.23 | CHF 70.88 | n/a | 23 |
| Aug ’24 | CHF 42.20 | CHF 86.26 +104.4% | 9.3% | CHF 98.03 | CHF 70.02 | CHF 42.20 | 23 |
| Jul ’24 | CHF 42.20 | CHF 86.16 +104.2% | 10.6% | CHF 100.29 | CHF 71.64 | CHF 42.20 | 23 |
| Jun ’24 | CHF 42.20 | CHF 88.29 +109.2% | 10.2% | CHF 101.49 | CHF 72.49 | CHF 42.20 | 23 |
| May ’24 | CHF 42.20 | CHF 87.31 +106.9% | 9.4% | CHF 99.47 | CHF 71.05 | CHF 42.20 | 23 |
| Apr ’24 | CHF 42.20 | CHF 94.00 +122.8% | 10.6% | CHF 114.95 | CHF 73.57 | CHF 42.20 | 23 |
| Mar ’24 | CHF 42.20 | CHF 95.93 +127.3% | 9.7% | CHF 116.67 | CHF 78.40 | CHF 42.20 | 23 |
| Feb ’24 | CHF 42.20 | CHF 93.21 +120.9% | 9.5% | CHF 114.43 | CHF 76.90 | CHF 42.20 | 23 |
| Jan ’24 | CHF 42.20 | CHF 87.47 +107.3% | 8.4% | CHF 106.86 | CHF 73.61 | CHF 42.20 | 24 |
| Dec ’23 | CHF 42.20 | CHF 87.82 +108.1% | 8.4% | CHF 107.76 | CHF 74.23 | CHF 42.20 | 24 |
| Nov ’23 | CHF 42.20 | CHF 92.27 +118.7% | 8.4% | CHF 115.01 | CHF 79.23 | CHF 42.20 | 24 |
| Oct ’23 | CHF 42.20 | CHF 92.39 +118.9% | 9.1% | CHF 111.11 | CHF 70.53 | CHF 42.20 | 24 |
| Sep ’23 | CHF 42.20 | CHF 90.41 +114.2% | 8.8% | CHF 108.43 | CHF 74.95 | CHF 42.20 | 24 |
| Aug ’23 | CHF 42.20 | CHF 90.78 +115.1% | 8.7% | CHF 109.27 | CHF 75.54 | CHF 42.20 | 25 |
Analyst Forecast: Target price is less than 20% higher than the current share price.